The Latest Breaking News from Marty Makary

Top health officials under the U.S. Health and Human Services Secretary Robert F. Kennedy Jr. are intensifying efforts to gather and publicize data on potential harms caused by COVID-19 vaccines, particularly in pregnant women.

Rise in cases south of the border prompts concern over US livestock as Trump budget cuts hit research and foreign aid

Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure.

FDA Commissioner Marty Makary warns ‘epidemic’ of e-cigarette use in high schools needs to be tackled

In May, FDA Commissioner Marty Makary named Vinay Prasad the next director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER). Within three months, Prasad resigned.

West Virginia is banning seven artificial dyes from school meals before the start of class

In a letter to the U.S. Food and Drug Administration (FDA) Commissioner Marty Makary on Friday, over 80 bipartisan members asked the agency to stop counterfeit and copycat versions of GLP-1 drugs like Novo Nordisk A/S’ (NYSE:NVO) Wegovy (semaglutide) and Eli Lilly and Co.’s (NYSE:LLY) Zepbound from flooding the market.

Democrats have accused Robert Kennedy Jr. of making claims without scientific research to back them and say his claims are dangerous.

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program